BioWorld

April 22, 1997

View Archived Issues

AutoImmune Stock Sinks On Disappointing Phase III Myloral Trial Data In MS

Read More

Other News to Note

Read More

Isis Starts First Pivotal Trial Of Antisense Drug For Crohn's Disease

Read More

How HIV Coat Protein Penetrates Target Cell By Sharp-Pointed, Spring-Loaded Mech

Read More

CEO, Co-Founder Invest Nearly $16M In Immune Response

Read More